fb-pixel tracker
News

Caris Life Sciences Announces Upcoming Launch of Caris Target Now Select™

Service will Offer Enhanced Biomarker Analysis for Cancers of the Breast, Colon, and Ovary, as well as NSCLC and Melanoma Irving, Tex., June 3, 2012 – Caris Life Sciences®, a leading biosciences company focused on enabling precise and personalized healthcare through molecular profiling and blood-based diagnostic services, announces the upcoming introduction of Caris Target Now … Continued

ASCO Presentations Highlight Clinical Utility of Caris Target Now™ in Molecular Profiling of Breast and Head and Neck Cancers

  – TLE3 Biomarker Over-expressed in HER2-positive, Hormone Receptor-positive, and Triple-negative Breast Cancers –   –EGFR status May Facilitate Therapeutic Decision-making in Head and Neck Cancer – Chicago, Ill., June 2, 2012 – Caris Life Sciences, announced today the utility of the company’s Caris Target Now™ evidence-based molecular profiling service in the characterization of breast … Continued

Caris Target Now™ Data to be Showcased at ASCO 2012

Evidence-Based Molecular Profiling Service to be Featured in Eight Separate Data Presentations   IRVING, TX, May 21, 2012 – Caris Life Sciences, a leading biosciences company focused on enabling precise and personalized healthcare through molecular profiling and blood-based diagnostic services, today announced that eight data presentations on Caris Target Now™, the foremost evidence-based molecular profiling … Continued

Circulating Microvesicles Demonstrate Promise for Cancer Testing

Three Posters on Novel Technology Presented at American Association for Cancer Research (AACR) IRVING, TX, April 4th, 2012 — Caris Life Sciences, a leading biosciences company focused on enabling precise and personalized healthcare through molecular profiling and blood-based diagnostic services, this weekend presented novel findings regarding the biological role of circulating microvesicles (cMV) in the … Continued

Novel Findings for Molecular Profiling of Head and Neck Squamous Cell Carcinoma (HNSCC) Presented at the 2012 Multidisciplinary Head & Neck Cancer Symposium

First Comprehensive Analysis of Biomarkers Associated with this Aggressive Form of Cancer Demonstrates Clinical Utility of Molecular Profiling in Identifying Treatment Options When Therapeutic Ambiguities Exist. IRVING, TX, February 2, 2012 – Caris Life Sciences™, Inc., a leading biosciences company focused on enabling precise and personalized healthcare through the highest quality molecular profiling and blood-based … Continued

Caris Life Sciences and Miraca Holdings Complete Sale of Anatomic Pathology Business

Tokyo, Japan & Irving, Texas – November 22, 2011 – Miraca Holdings Inc. (“Miraca”), Japan’s largest clinical diagnostics and laboratory testing service provider, and Caris Life Sciences, Inc. (“CLS”), a privately-held company headquartered in Texas specializing in the development and commercialization of the highest quality anatomic pathology, molecular profiling, and blood-based diagnostic technologies, today announced … Continued

Caris Life Sciences Presents Study at AACR-NCI-EORTC International Conference

Data Highlights How the Information Provided by Molecular Profiling Can Be Useful in Guiding Therapy Selection for Advanced Prostate Cancer IRVING, Texas – November 17, 2011 – Caris Life Sciences™, Inc., a leading biosciences company focused on enabling precise and personalized healthcare through the highest quality anatomic pathology, molecular profiling, and blood-based diagnostic services, this … Continued

Caris Life Sciences Reports Key Findings at the 59th Annual Scientific Meeting of the American Society of Cytopathology

Data Highlights Clinical Utility of Molecular Profiling in Absence of Traditional Tissue Samples IRVING, Texas – November 8, 2011 – Caris Life Sciences, Inc.™, a leading biosciences company focused on enabling precise and personalized healthcare through the highest quality anatomic pathology, molecular profiling and blood-based diagnostics, prognostic and theranostic services, announced today that Erika Fong, … Continued

Kathleen Danenberg Joins Caris Life Sciences’ Executive Team as Senior Vice President, Professional Affairs

Newly Added Position Will Develop and Expand Molecular Profiling Clinical Trial Strategy IRVING, Texas – October 19, 2011 – Caris Life Sciences, Inc.™, a leading biosciences company focused on enabling precise and personalized healthcare through the highest quality anatomic pathology, molecular profiling, and blood-based diagnostic, prognostic and theranostic services, announced today that Kathleen Danenberg has … Continued

Caris Life Sciences Highlights Gene Expression Profiling Findings at 12th Annual International Congress of Human Genetics

Data Presented Shows Clinical Utility of Molecular Profiling Helping Physicians Select More Effective Therapeutic Treatments for Cancer Patients   IRVING, TX, October 14-15, 2011 — Caris Life Sciences™, Inc., a leading biosciences company focused on enabling precise and personalized healthcare through the highest quality molecular profiling, and blood-based diagnostic services, presented this week at the … Continued

1 16 17 18 19 20

About Our News

Search to find the latest new about Caris Molecular Intelligence®, sign up for news alerts, and be sure to follow us on social media.